Regeneron | Pushing the Bounds of Science
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Regeneron Pharmaceuticals - Wikipedia
Regeneron has developed aflibercept, a VEGF inhibitor, and rilonacept, an interleukin-1 blocker. VEGF is a protein that normally stimulates the growth of blood vessels, and interleukin-1 is a …
Investor Relations | Regeneron Pharmaceuticals Inc.
7 hours ago · Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Learn more …
Regeneron Enters into Asset Purchase Agreement to Acquire …
May 19, 2025 · Regeneron will prioritize the privacy, security and ethical use of 23andMe’s customer data; stands ready to work with independent, court-appointed Customer Privacy …
Regeneron's weight-loss drug helps patients on Wegovy preserve …
6 days ago · Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in combination with Novo Nordisk's popular …
PUSH THE BOUNDS OF SCIENCE - Regeneron
Regeneron is a leading science and technology company dedicated to inventing, developing and commercializing life-transforming treatments for serious diseases.
About Regeneron | Our Company
Regeneron's medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, …
Regeneron Expands Clinical-Stage Obesity Portfolio with Strategic …
6 days ago · New licensing agreement with Hansoh Pharma provides Regeneron with HS-20094, a GLP-1/GIP receptor agonist in advanced stages of clinical development in China. Phase 2 …
Regeneron Locations | Offices Across the Globe
Find addresses and contact information for Regeneron offices worldwide with locations across North America, Europe and Asia.
Regeneron | Investigational Pipeline and Medicines in Development
Apr 30, 2025 · Explore Regeneron’s clinical pipeline. Our pipeline is powered by end-to-end research and development capabilities, and our portfolio of investigational medicines reflects …